P2607 - Medical Director, Oncology, Lausanne

Medical Director, Oncology

Location:

Lausanne, Switzerland Department:

Clinical Development Contract:

permanent role, full-time. Executive Summary

As a

Medical Director, Oncology , you will serve as the visionary clinical leader for the global development of transformative compounds. You will design and execute end-to-end clinical strategies—from First-in-Human through Phase 2 to address critical unmet medical needs and achieve Debiopharm’s overarching business objectives.Key Responsibilities

Strategic Leadership:

Develop and lead the global clinical strategy for assigned oncology programs, accounting for medical practice trends and the competitive landscape. Clinical Deliverables:

Provide medical input for all key documents, including study protocols, Investigator Brochures, and regulatory registration dossiers. Program Execution:

Deliver the Clinical Development Plan (CDP) in collaboration with study teams, ensuring efficient protocol execution and medical monitoring. Matrix Collaboration:

Drive clinical programs in partnership with Project Management, Clinical Operations, Biostatistics, and Regulatory Affairs to meet decision milestones. Decision Support:

Generate scenarios and risk-management strategies to inform senior leadership and support decision-making. Network Building:

Develop and maintain a global network of Key Opinion Leaders (KOLs), investigators, and patient advocacy groups. Stakeholder Interaction:

Represent the clinical program before regulatory authorities, data monitoring boards, and internal decision boards. Business Support:

Provide medical expertise to support in-/out-licensing activities and market access strategies. Profile Required

Medical Credentials:

Medical Doctor (MD) with significant clinical experience in oncology, specifically in solid tumors. Industry Experience:

At least 2 to 5 years of proven success in early-stage oncology drug development (FIH to Phase 2) within the pharmaceutical industry. Specialized Expertise:

Experience in antibody-drug conjugates (ADCs) or radio-oncology is highly preferred. Leadership Track Record:

Demonstrated ability to lead at least one oncology development program through early stages within a matrix organization. Strategic Mindset:

Proven strategic thinker with an innovative mindset, capable of managing uncertainty and driving decisive risk-based actions. Technical Mastery:

Thorough knowledge of GCP, clinical trial design, statistical methodology, and global regulatory development processes. Collaborative Spirit:

Strong ability to establish scientific partnerships with external stakeholders and internal cross-functional teams. Agile Mindset:

Entrepreneurial and autonomous approach, combined with high medical curiosity and a commitment to staying current with scientific progress. What we Offer

Being part of a company where innovation, collaboration, and impact aren’t just values — they’re how we work every day Partner with teams across disciplines, at the forefront of oncology and anti-infective development An inclusive and respectful workplace — proud to be Equal-Pay certifiedGrow in a culture that values people, purpose, and performance A chance to grow, share, and shape the future of healthcare

#J-18808-Ljbffr